Pulmonary Rota cap in pharma franchise in Manipur

Pulmonary Rota cap in PCD pharma franchise in Chandigarh

Pulmonary Rota cap in top pharma company in Sikkim

Pulmonary Rota cap in pcd pharma supplier in Bhopal

Pulmonary Rota capin phama franchise company in India
Pulmonary Rota cap in phama distributor in Patna

Buditerm GF Rota Capsule

Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule

Dosage Form : Rota cap

Packaging Type : in a bottle, silica gel,with carton

Packaging : 30 Capsules

Price : ₹549/-

Please Contact For Best Price

Buditerm GF is a powerful inhalation therapy designed for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. Each Rota Cap contains a carefully balanced combination of Glycopyrronium (25 mcg), Formoterol (12 mcg), and Budesonide (400 mcg). This unique formulation targets multiple pathways to provide comprehensive relief from respiratory symptoms, improving overall lung function and quality of life.

Glycopyrronium is an anticholinergic agent that helps to relax the muscles around the airways, leading to bronchodilation and improved airflow. Formoterol, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors, further enhancing bronchodilation and providing prolonged relief from wheezing and shortness of breath. Budesonide, an inhaled corticosteroid (ICS), works to reduce inflammation in the airways, addressing the underlying causes of asthma and COPD. Together, these three components create a synergistic effect that not only alleviates symptoms but also helps to prevent exacerbations.

Read More

About the Product

Buditerm GF is a powerful inhalation therapy designed for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. Each Rota Cap contains a carefully balanced combination of Glycopyrronium (25 mcg), Formoterol (12 mcg), and Budesonide (400 mcg). This unique formulation targets multiple pathways to provide comprehensive relief from respiratory symptoms, improving overall lung function and quality of life.

Glycopyrronium is an anticholinergic agent that helps to relax the muscles around the airways, leading to bronchodilation and improved airflow. Formoterol, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors, further enhancing bronchodilation and providing prolonged relief from wheezing and shortness of breath. Budesonide, an inhaled corticosteroid (ICS), works to reduce inflammation in the airways, addressing the underlying causes of asthma and COPD. Together, these three components create a synergistic effect that not only alleviates symptoms but also helps to prevent exacerbations.

Common side effects may include throat irritation, hoarseness, headache, and increased risk of respiratory infections. Some patients may also experience palpitations or muscle cramps. It is important to monitor for any unusual symptoms during treatment.

Glycopryl FB is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults.

Glycopryl FB should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen.

Store Glycopryl FB in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to ensure safety.

Get in Touch